VOR vs. VT
VOR (Vor Biopharma Inc.) is a stock, while VT (Vanguard Total World Stock ETF) is Global Equities fund tracking the FTSE Global All Cap Index. Over the past 5 years, VOR returned -48.26%/yr vs 10.51%/yr for VT. At a 0.27 correlation, their price movements are largely independent.
Performance
VOR vs. VT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VOR achieves a 13.53% return, which is significantly higher than VT's 10.06% return.
VOR
- 1D
- -0.60%
- 1M
- 3.63%
- YTD
- 13.53%
- 6M
- 9.76%
- 1Y
- 156.03%
- 3Y*
- -44.36%
- 5Y*
- -48.26%
- 10Y*
- —
VT
- 1D
- -2.05%
- 1M
- -0.44%
- YTD
- 10.06%
- 6M
- 9.32%
- 1Y
- 25.71%
- 3Y*
- 19.92%
- 5Y*
- 10.51%
- 10Y*
- 12.96%
VOR vs. VT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 13.53% | -41.08% | -50.67% | -66.17% | -42.77% | -72.35% |
VT Vanguard Total World Stock ETF | 10.06% | 22.43% | 16.49% | 22.02% | -18.00% | 13.98% |
Correlation
The correlation between VOR and VT is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2021 | 0.27 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VOR vs. VT — Risk / Return Rank
VOR
VT
VOR vs. VT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VOR | VT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.97 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.35 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.80 | 2.67 | -0.87 |
| Martin ratioReturn relative to average drawdown | 2.54 | 11.57 | -9.04 |
Loading charts...
Drawdowns
VOR vs. VT - Drawdown Comparison
The maximum VOR drawdown since its inception was -99.72%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for VOR and VT.
Loading charts...
Drawdown Indicators
| VOR | VT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -50.27% | -49.45% |
Max Drawdown (1Y)Largest decline over 1 year | -87.15% | -9.67% | -77.48% |
Max Drawdown (3Y)Largest decline over 3 years | -96.49% | -16.51% | -79.98% |
Max Drawdown (5Y)Largest decline over 5 years | -99.29% | -26.38% | -72.91% |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.24% | — |
Current DrawdownCurrent decline from peak | -98.63% | -2.80% | -95.83% |
Average DrawdownAverage peak-to-trough decline | -88.73% | -7.00% | -81.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.73% | 2.23% | +59.50% |
Volatility
VOR vs. VT - Volatility Comparison
Vor Biopharma Inc. (VOR) has a higher volatility of 21.30% compared to Vanguard Total World Stock ETF (VT) at 5.65%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VOR | VT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.30% | 5.65% | +15.65% |
Volatility (6M)Calculated over the trailing 6-month period | 63.03% | 11.32% | +51.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 169.42% | 13.58% | +155.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.43% | 16.19% | +100.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.53% | 17.20% | +99.33% |
Dividends
VOR vs. VT - Dividend Comparison
VOR has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VT Vanguard Total World Stock ETF | 1.61% | 1.82% | 1.95% | 2.08% | 2.20% | 1.82% | 1.66% | 2.32% | 2.53% | 2.11% | 2.39% | 2.45% |
Frequently Asked Questions
VOR and VT have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VOR has higher volatility (21.30%) compared to VT (5.65%). In terms of maximum drawdown, VOR dropped -99.72% vs VT's -50.27%.
VT currently has the higher Sharpe Ratio (1.91 vs 0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VOR and VT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer